Site US10010 — Chicago, Illinois

Site US10010 is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Site US10010 has participated in 3 clinical trials.

Therapeutic areas: Kidney Transplantation, Clostridium Difficile-associated Diarrhea (CDAD).

Sponsors: Astellas Pharma Global Development, Inc., Astellas Pharma Europe B.V..

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10010?

Site US10010 has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10010 conducted?

Site US10010 has 3 clinical trials on record. Their work covers Kidney Transplantation, Clostridium Difficile-associated Diarrhea (CDAD).

Is Site US10010 accredited by Crixeo Health?

Site US10010 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10010?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.